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THE INFLUENCE OF ALCOHOL ON TELOMERE LENGTH AND 
SHELTERIN COMPLEX GENE EXPRESSION IN HUMAN EMBRYONIC 
STEM CELLS 
 
MUHAMMAD TALHA MOAZZAM 
 
ABSTRACT 
Background: Telomeres are specialized heterochromatic structures found at the ends of 
chromosomes that serve to protect the integrity of the genome. Theoretically, telomeres, 
and thereby chromosomes, should be constantly shortening however that is not the case. 
Telomere length homeostasis is maintained via the activity of the enzyme Telomerase as 
well as a complex of 6 proteins, called the shelterin complex. Decreased telomere length 
is associated with a variety of neuropsychological diseases such as Alzheimer’s disease, 
and chronic depression.  
Objective: The primary objective was to understand the effect of alcohol exposure on 
telomere dynamics, specifically on telomere length as well as the expression of the 
shelterin complex genes. This was accomplished using human embryonic stem cells 
(hESCs) as models. This study was exploratory with the goal of increasing our 
knowledge of genes involved in telomere maintenance. 
Methods: hESCs were cultured in cell culture media containing 25 mM, 50 mM, or 100 
mM of ethanol. After a 3-, 7-, or 14-day ethanol exposure plus a 24-hour withdrawal, 
hESCs were collected and genomic DNAs and total RNAs was extracted. Ethanol-
  vi 
induced telomere length changes were examined by quantitative polymerase chain 
reactions (qPCR). Ethanol-induced shelterin complex gene expression changes were 
examined by reverse-transcription and quantitative polymerase chain reactions (RT-
qPCRs).  
Results: Extended alcohol exposure exerted a deleterious effect on telomeres, causing 
them to diminish in length. The effects of alcohol on the expression of shelterin complex 
genes were varied, ranging from consistent upregulation or downregulation to a 
combination of both. The concentration of alcohol was inversely correlated with the 
expression of shelterin complex genes, and the correlation was influenced by the duration 
of ethanol exposure. 
Conclusion: Chronic exposure to alcohol resulted in the shortening of telomeres. The 
effect ethanol was both time- and concentration-dependent, with telomere length having a 
negative relationship with the concentration of ethanol as well as the duration of 
exposure. Additionally, the shelterin subunit genes had their expression levels altered by 
ethanol in a manner which was consistent with what has been observed in prior studies as 
well as what aligns with their respective functions.  
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INTRODUCTION 
Background of the telomere 
Telomeres are specialized heterochromatic structures found at the end of linear 
chromosomes. They serve to protect the integrity of the genome in eukaryotic 
chromosomes by preventing their rearrangement or fusion. They also allow the ends of 
the linear DNA molecule to replicate completely. Telomere function can be summarized 
into four fundamental roles: it is responsible for sheltering genetic information, 
distinguishing and protecting the ends of the chromosome from DNA damage, serve as a 
docking site for DNA repair proteins and provide information on the history of a cell’s 
proliferation. 
 Telomeres are composed of series of DNA sequence repeats of the nucleotides 
TTAGGG (Greider and Blackburn, 1996). At their 3’ ends, they are composed of single 
stranded DNA overhang. As a consequence of the nature of the DNA replication 
machinery, the 3’ end of the DNA strand is incompletely copied, and this leads to the 
attrition and eventual shortening of the telomere.  
Telomere associated pathologies 
 In recent times, the telomere has started to gain prominence as a potential 
biomarker for several pathologies that are heavily researched in the field of scientific 
academia. As such, the telomere and its dynamics are starting to get extensively 
documented. Telomere associated pathologies are not localized to a single area, rather, its 
repertoire of diseases is widespread. Patients suffering from rheumatoid arthritis, for 
example, have been shown to possess epithelial cells with a shorter telomere length in the 
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joints that were affected compared to healthy epithelial cells (Steer et al., 2007). 
Similarly, telomere shortening in the CD8 cell line results in patients suffering from 
chronic Human Immunodeficiency Virus (HIV) invasion (Effros et al. 1996). Shortened 
telomeres in peripheral blood mononuclear cells led to its association in the pathology of 
neurological conditions such as Down Syndrome and Alzheimer’s Disease. (Zhang et al. 
2010).   
Human research of telomere biology has suggested the influence of 
psychological, socio-environmental, or behavioral factors on telomere length 
(Starkweather et al., 2014). One such stressor that is being extensively studied is alcohol. 
The study of alcohol is a complex one as it not only involves the stress induced upon the 
molecular machinery directly, but the overlying causes of alcohol consumption, such as 
depression, stress and mood disorders also must be accounted for. Chronic alcohol 
consumption has been reported to be associated with age-related diseases and mortality 
(Spencer and Hutchison, 1999). While the exact relationship between telomere length and 
alcohol consumption is unknown, there is a bevy of literature that suggests that the two 
are in fact, correlated. The general consensus among the scientific community is the 
result of a transitive relationship: Alcohol consumption has been linked to the aging of 
cells and since telomere length is also implicated in age-related cellular disorders, a 
relationship between alcohol and telomere length was deduced. Studies have suggested 
that alcohol consumption results in the exacerbation of oxidative stress and telomere 
shortening (Pavanello et al., 2011; Strandberg et al., 2012). One study even showed that 
telomere length in healthy patients was almost twice that of alcohol abusers (Pavanello et 
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al., 2011).  Given the high prevalence of alcohol use disorders, which affects over 15 
million people in the United States alone, every facet of this disease is being subjected to 
research, the effects of alcohol consumption on telomere length being one of them. It is 
hypothesized that the consumption of alcohol, both recreationally (acute) and chronically 
(AUD), will result in the shortening of telomeres and all the symptoms associated with 
this phenomenon. 
Maintenance of the telomere 
Despite the constant replication and shortening of the chromosome, it does not get 
fully reduced to a nonfunctional state. Rather, the shortening can be decelerated. This is 
accomplished by the enzyme, telomerase. Discovered in 1978, telomerase is a 
ribonucleoprotein complex that allows progressive synthesis of TTAGGG telomeric 
repeats at the 3’ ends of linear chromosomes (Greider and Blackburn, 1996). This 
synthesis of repeats is what counteracts the loss of DNA from each round of replication. 
Telomerase is a reverse transcriptase, that is, a RNA containing DNA polymerase that 
consists of two subunits: TERT and TERC (Cohen et al., 2007). TERT, telomerase 
reverse transcriptase, as the name suggests, is the constituent of telomerase that allows its 
reverse transcriptase activity. It is a ribonucleoprotein encoded by a 40kb gene, hTERT in 
humans, which is located at chromosome 5p15.33 (Jafri, Ansari, Alqahtani, & Shay, 
2016). hTERT is rich in GC pairs and lacks TATA and CAAT boxes (Takakura et al., 
1999). Its expression is possible due to the presence of a multitude of binding sites for a 
variety of transcription factors (Takakura et al., 1999). This also implies that hTERT’s 
expression is regulated by a diverse array of factors. TERC, telomerase RNA component 
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is the essential RNA component of telomerase. It is encoded by the hTERC gene found in 
chromosome 3q26 (Jafri, Ansari, Alqahtani, & Shay, 2016). TERC serves the function of 
acting as a template for the synthesis of telomeric DNA. It also partakes in the 
localization, assembly and the catalysis of telomerase (Zhang, Kim, & Feigon, 2011). 
Telomerase is also comprised of accessory units, including dyskerin, pontin, reptin, 
GAR1, NHP2 and ribonucleoprotein NOP10 (Jafri, Ansari, Alqahtani, & Shay, 2016). 
Most of these play a role in assisting the proper formation of the telomerase holoenzyme.  
Telomerase maintains the telomere through a process that involves multiple key 
steps and proteins. TERT must first be transported and translocated into the nucleus of 
the cell. This is followed by the formation of a complex between TERT and TERC along 
with the necessary accessory components. This complex is then recruited to the telomere 
when DNA replication is taking place. More specifically, it is recruited after the 
replication fork has formed and remodeled the 3’ ends of the DNA during the S-phase of 
the cell cycle. This recruitment is accomplished via subunits of the shelterin complex, 
which is also referred to as the telosome. 
 The TTAGGG repeats on mammalian telomeres associate with a six-protein 
complex, called shelterin. It consists of DNA binding proteins that bind to both single and 
double stranded telomeric DNA (Figure 1). It also associates with and signal other 
proteins to attain telomeric end protection (Figure 2). The shelterin complex regulates the 
activity of telomerase in telomere maintenance and allows cells to be able to distinguish 
the difference between natural chromosome ends and DNA damage (De Lange, 2005). It 
contains six telomere associated proteins: TRF1, TRF2, RAP1, POT1, TIN2, and ACD 
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(also known as TPP1) (Palm and De Lange, 2008). All these components localize 
specifically to the telomere at every stage of the cell cycle and do not function anywhere 
else in the nucleus. 
 
Figure 1: The shelterin complex as it is observed in mammals as it recruits 
telomere reverse transcriptase, which is the complex on the right side of the graphic.  
(Schmutz and De Lange, 2016) 
 
The shelterin complex is capable of binding specifically to the telomeric DNA 
sequence because three of its subunits, Telomeric Repeat Binding Factors 1 and 2 (TRF1 
and TRF2) and Protection of Telomeres (POT1) can recognize its landmark TTAGGG 
repeats (de Lange, 2005).  TRF1 and TRF2 bind the double stranded DNA of the 
telomeres while POT1 binds single stranded TTAGGG repeats that are found at the 3’ 
overhang of telomeric DNA (de Lange, 2005). Other members of the complex are 
associated to and interact with either of these subunits. The purpose of these interactions 
is to stabilize the associations of the DNA binding subunits of the complex with the DNA 
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itself as well as to recruit telomerase and other accessory factors to ensure optimal 
maintenance of the telomere.  
 
Figure 2: The telomere interactome shows most known protein interactions 
performed by subunits of the shelterin complex. The telosome is enclosed in the green 
shaded circle. Lines indicate protein interactions, nodes are indicated by yellow circles 
and red circles are protein hubs. Obtained from Xin et al. 2008. 
 
TRF1 and TRF2 both bind telomeric double stranded DNA. They both possess 
carboxy terminal Myb domains which are required for their binding to the telomere 
duplex DNA (Erdel et al., 2017). They bind to the DNA in the form of homodimers and 
this dimerization is mediated by the TRF-homology domain (TRFH) (Fairall, Chapman, 
Moss, de Lange, & Rhodes, 2001). TRF1 tends to bind with long tracts of DNA, while 
TRF2 prefers to bind to the point of intersection between single and double stranded 
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DNA (Stansel, de Lange, & Griffith, 2001). This difference in binding could be since 
human TRF1 and TRF2 differ in their amino termini, however there is no solid evidence 
to support this. The N-terminus of TRF1 is composed of acidic amino acids while TRF2 
is basic, containing an amino terminus with a Gly/Arg-rich domain (Palm & de Lange, 
2008). Studies have also shown that the basic region of TRF2 could play a role in the 
supercoiling of telomeric DNA as well as the stabilization of the T-loop structure, which 
is the region of repetitive nucleotides at the end of a chromosome (Fouché et al., 2006). 
Furthermore, a lack of TRF2 has been shown to disrupt telomere end protection and 
induce apoptosis (Karlseder, Broccoli, Dai, Hardy, & de Lange, 1999). TRF2’s major 
functions involve the stabilization of the telomeric loop as well as the protection of the 
telomere end structures that form as a result of the 3’ overhang invading the telomeric 
repeats (de Lange, 2018). TRF1 homodimers are thought to monitor telomere length. An 
overexpression of TRF1 has been shown to be associated with shorter telomeres while 
knockouts or mutants of this gene result in elongated telomeres (Iwano, Tachibana, 
Reth, & Shinkai, 2004).  TRF1 and TRF2 do not interact directly with one another. 
Apart from these functions, TRF1 and TRF2 serve as hubs for protein interactions 
within the telomere interactome. They are responsible for the recruitment of the other 
four shelterin subunits and interact and associate with a wide array of proteins that are 
involved in a multitude of functions of the cell cycle, DNA repair, recombination as well 
as proteins that maintain telomere structure and length (Figure 2). In fact, it is 
hypothesized that TRF1 performs its function via its interactions with the shelterin 
proteins TINF2, ACD and POT1. It interacts with a protein inhibitor of telomerase, 
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PINX1 in order to negatively regulate telomere length (Zhou & Lu, 2001). The 
recruitment is made possible due to TRF1 and TRF2 containing a versatile peptide 
docking domain (Palm and de Lange 2008). The TRFH domains of TRF1 and TRF2 
recognize different target proteins allowing them to recruit specific factors that act as 
accessories to the telomere. For the TRFH domain to recognize a target, the target protein 
must possess a F/YxLxP motif (Palm and de Lange 2008).  
POT1 is a telomeric subunit that has been determined to support an essential role 
in the maintenance of telomere integrity. This was discovered through the investigation 
of mice telomeres which contain two isoforms of POT1, POT1a and b (Xin, Liu, & 
Songyang, 2008). Knocking out either of these would result in defective telomeric 
dynamics and as such, it was concluded that both subunits are needed for wholistic 
protection and maintenance of the telomere. POT1a is responsible for the suppression of 
DNA damage responses and POT1b protects the 3’ single stranded DNA overhangs from 
nucleases (Xin, Liu, & Songyang, 2008). While POT1 binds telomeric DNA like TRF2, 
the pathway it utilizes is not the same. TRF2 protects telomeric events by evading DNA 
damage responses mediated by the ataxia telangiectasia mutated (ATM) pathway, 
whereas POT1 protects the telomere from damage response pathways initiated by the 
protein kinase ATR (ataxia telangiectasia and Rad3-related protein) (Palm and de Lange, 
2008). POT1 represses the ATR pathway by binding telomeric single stranded DNA as 
well as its inhibition of ATR activation by blocking the single strand binding protein 
RPA, which is responsible for recruiting ATR to the telomere (de Lange, 2005).  
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POT1 was discovered because its sequence is homologous to the alpha subunit of 
the TEBP α/β telomeric binding complex (Xin, Liu, & Songyang, 2008). This complex 
binds the short telomeric overhands and hides the 3’ end in a hydrophobic pocket. POT1, 
like TEBPα, consists of two OB folds in its amino terminus (Horvath, Schweiker, 
Bevilacqua, Ruggles, & Schultz, 1998). These are common protein domains that are often 
used for recognizing single stranded DNA. Consequently, they serve a function akin to 
the Myb domains for TRF1 and TRF2 in that they allow POT1 to recognize the G-strand 
telomeric sequence.  
 TEBPα contains three OB folds in total, two of which are involved in the 
recognition of single stranded DNA, while the third serves to interact with TEBFβ (Xin, 
Liu, & Songyang, 2008). Another shelterin subunit, ACD, has been shown to have an OB 
fold structure with considerable homology to those present in TEBFβ (Xin et al., 2007). 
Despite the presence of OB folds, ACD shows no capability of binding to single stranded 
DNA. It has, however, been shown to form a ternary complex of POT1/ACD/DNA (Xin, 
Liu, & Songyang, 2008). ACD is responsible for enhancing the DNA binding activity of 
POT1. This suggests that POT1 interacts with DNA in the form of a heterodimer with 
ACD. It is postulated that the ACD/POT1 heterodimer is responsible for the modulation 
of telomerase access to telomeres. This is supported by the fact that the N terminus OB 
fold domain of ACD interacts with telomerase (Palm and de Lange, 2008). ACD has also 
been shown to connect POT1 with TINF2 by effectively acting as a bridge between the 
two via its POT1 interaction domain, located centrally, and its TINF2 interaction domain, 
found at its C-terminal (Frescas & de Lange, 2014). The complex of ACD and TINF2 to 
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POT1 allows linkage between it and the dsDNA binding shelterin subunits, TRF1 and 
TRF2 (Xin, Liu, & Songyang, 2008). This linkage is assumed to the critical method of the 
recruitment of POT1 to telomeres.  There is conflicting data regarding this hypothesis: 
Some studies have reported that in the absence of ACD, some POT1 was still recruited to 
the telomere and weak interactions occurred between POT1 and TRF2, suggesting that 
this complex is not essential for POT1 recruitment. Support for this notion is found in a 
study performed by Takai et al. in which POT1 recruitment failed in the absence of either 
ACD or TIN2, suggesting that TIN2 could mildly compensate for any ACD dysfunction 
(Takai, Kibe, Donigian, Frescas, & de Lange, 2011).  Other studies have shown that in 
the absence of ACD or presence of ACD mutants that cannot bind POT1, there was no 
detectable POT1 in the telomeres (Palm and de Lange, 2008). Additional studies have 
also reported that impaired ACD function leads to telomere deprotection and telomere 
length deficiencies consistent with the loss of POT1 (Xin et al., 2007).  
TINF2 is in a central position in the shelterin complex. It is capable of binding to 
TRF1, TRF2, and ACD (Figure 1). It therefore can form a bridge between the shelterin 
complex components that bind both single and double stranded DNA. The C-terminus of 
TINF2 possesses an FxLxP motif that allows it to be recognized by and bind to the TRFH 
domain of TRF1 (de Lange, 2018). The N-terminus of TINF2 associates with the hinge 
region of TRF2. The binding of TINF2 to TRF1 and TRF2 occurs simultaneously (Palm 
& de Lange, 2008). Silencing the genes of TINF2 or expression of mutant variants had a 
destabilizing effect on the shelterin complex as it is essential for the formation of a bridge 
between TRF1 and TRF2 (Palm and de Lange, 2008). The N-terminus of TINF2 also 
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allows it to recruit ACD, and by relation, POT1 (Palm and de Lange, 2008). This 
interaction occurs at a site distinct from the TRF2 binding site. This is supported by the 
fact that a complex can be formed between TRF2/TINF2/ACD and ACD reinforces the 
interaction between TRF2 and TINF2.  
RAP1 is an essential, poorly characterized protein that plays a vital role in the 
maintenance of telomere length. Its discovery was the outcome of a study that found that 
it was capable of both inducing and inhibiting gene expression, hence the name Repressor 
Activator Protein 1. It is an abundant protein that is located in both telomeric and non-
telomeric loci. It is estimated that for the average telomere, which has a length of 300 
base pairs, each telomere will be interacting with 15-20 RAP1 molecules (Wright and 
Zakian 1995). Double stranded telomeric repeat DNA contains high affinity binding sites 
for RAP1 every 20 base pairs (Wellinger & Zakian, 2012). In mammals, it does not bind 
directly to the telomeric DNA sequence (Figure 1). Rather, its recruitment to the 
telomeric DNA sequence, as well as its other binding sites, is highly dependent on its 
interactions with TRF2 (Li, Oestreich, & de Lange, 2000): RAP1 is almost completely 
lost in the absence of TRF2 (Palm, DeLange 2008).  
Incidentally, the amount of telomere bound RAP1 and Rif1/2, which bind to it at a 
locus different from the shelterin binding site, determine the length of the telomere. 
However, the exact mechanism of this is unknown. A deficiency in RAP1 results in 
overexpression of genes within the 3’ sub telomeric region (Lue & Autexier, 2012). Its 
effects are not limited to the telomere: deficiency also leads to dysregulation of genes 
associated with cell adhesion, and metabolism (Martinez et al, 2010).  
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The functions of RAP1 include protecting telomeres from telomere fusion and 
sheltering them from activation of the DNA damage checkpoint. It also serves a 
protective role for the telomere, which is the result of its RCT domain. This domain is 
responsible for the recruitment of shelterin proteins Rif1/Rif2 as well as gene silencing 
protein complex Sir3/Sir4 (Yang et al., 2017). Yeasts have three complexes that protect 
the telomere by capping it: RAP1–Rif1–Rif2, Yku70–Yku80 and the Cdc13–Stn–Ten1 
(CST) complexes. The RAP1-Rif1-Rif2 complex causes a negative feedback loop that 
regulates the actions of telomerase (Yang et al., 2017). Rif1 and Rif2 play a role in 
masking the ends of the telomere, thereby preventing G2/M checkpoint activation in the 
cell cycle (Yang et al., 2017). Rif1 intereacts with RAP1 in order to maintain telomere 
length homeostasis, which is the balance between telomerase induced elongation and 
telomere capping (Dan et al., 2014). It is essential for the viability of the cell if the CST 
complex is malfunctioning.   
In yeast, RAP1 is a negative regulator of telomere length. In human cells however, 
RAP1 causes the extension of telomeres as it was shown that inhibition of the human 
homologue of RAP1 resulted in longer telomeres (O’Connor et al. 2004). It also interacts 
with proteins involved in the damage response pathway, including Rad59, Mre11, 
Ku70/86, and PARP1 (O’Connor et al. 2004). The interactions of RAP1 with MRN and 
Ku complexes have been shown to be independent of TRF2 and involve multiple 
domains, the RCT and BRCT domains (Li & de Lange, 2003). These complexes regulate 
double-stranded DNA break repair and homologous recombination. Ku70/86 complex 
specifically has been shown to perform these functions while the MRN complex regulates 
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telomere length in a Ku-dependent manner (O’Connor et al. 2004). Ku70 can bind 
directly with TRF2 and has been proposed to be a direct regulator of human telomerase 
(Song et al, 2009). Therefore, it is possible that RAP1 and TRF2 regulate telomerase by 
regulating the Ku complex, however, this is not the only negative regulator recruited by 
RAP1, as shown by linker region deletion studies (O’Connor et al., 2008). PARP1 either 
binds to RAP1 at the RCT domain or indirectly via TRF2 (Palm and DeLange 2008). Its 
function is to maintain chromatin structure when it is exposed to stress. Furthermore, 
RAP1 works together with TRF2 to recruit DNA damage response proteins for telomere 
maintenance. When the RCT domain of RAP1 was knocked out, RAP1’s ability to extend 
telomere length was highly impaired (O’Connor et al. 2004). This could be since RAP1’s 
ability to bind TRF2 has been rendered dysfunctional. Deletion analysis in the linker 
region of RAP1 showed that a deficiency or mutation of the linker region led to a 
reduction in telomere length and the number of TRF2 foci in cells (Li & de Lange, 2003). 
This suggests that while RAP1 can still interact with TRF2 in the absence of the linker 
region, it is necessary for the interaction between TRF2 and the telomeric DNA. Another 
possibility exists in that the linker region may be involved in the recruitment of other 
negative regulators of telomere length which could explain these findings. 
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SPECIFIC AIMS 
Several studies have investigated the effects of ethanol on human telomeres as 
well as on the effects of stress on telomere length. However, no study has investigated the 
effects of ethanol on telomere length in in vitro stem cell models. A prior study, also 
looking at the effects of alcohol consumption on telomere dynamics, showed that 
telomere length was reduced as a result of EtOH exposure and that a variety of pathways 
worked in tandem to cause this shortening (Harpaz et al., 2018). An even earlier studied 
demonstrated that telomere length was markedly increased as a result of EtOH exposure 
(Romano et al. 2013) and therefore, there is uncertainty as to the effect that alcohol 
exposure has on telomere dynamics. As such, this study aims to provide further support 
to either side of this controversy while also elucidating the effects this exposure has on 
the shelterin complex.  
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METHODS  
 
Preparation of RNA in order to study Shelterin Gene Expression 
Cell Culture 
Human embryonic stem cells were obtained from the WiCell Research institute, 
Madison, Wisconsin, USA. These cells were grown on Vitronectin from Thermofisher in 
a feeder free culture system and maintained in Essential 8TM Medium. The following 
atmospheric conditions were maintained for optimal colony proliferation: 5% CO2 and 
100% relative humidity. In order to prevent the differentiation of the cells, their media 
was changed every 24 hours. Cells were treated with ethanol for this study, which was 
added directly to the media on the days of treatment. Cells were passaged at 
approximately 80% confluency via ReLeSRTM from StemCell Technologies and were 
split followed by the addition of ROCK inhibitor for a day. These cells were then 
harvested in DPBS, spun and the supernatant was removed from the pellet. The cells 
were then store in a -80°C freezer until further analysis was to be performed. 
RNA Extraction 
 Total RNAs were extracted from ethanol-exposed or -unexposed hESCs using 
QIAGEN miRNeasy kit. 140 uL of chloroform was added to the tube with hESCs. After 
a couple of minutes, the tube was centrifuged for 15 min at 12,000g at 4°C. This caused 
the sample to separate into 3 phases: the upper phase was aqueous and colorless and 
contained the RNA, the intermediate phase was white and cloudy, and a lower organic 
phase. The upper phase was carefully extracted, ensuring that neither of the other two 
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phases was extracted alongside it. 1.5x the volume of the RNA phase was determined and 
ethanol equal to this value was added and mixed to the RNA phase. This step, involving 
the addition of ethanol to the RNA phase, is repeated once more and the flow-through is 
discarded. 700uL of Buffer RWT are then added to the spin column with the RNA and 
this is centrifuged for 15sec at 8,000g. The flow through was discarded once again. 
500uL of Buffer RPE was added into the spin column and it was once again centrifuged 
with the same parameters. Another 500uL of Buffer RPE was added to the spin column 
and this time, it was centrifuged for 2 min at 8,000g. The spin column was added to a 
new tube and 50 ul of RNase free water was added and the column was centrifuged for 1 
min at 8000g. After this, the remaining sample was taken to the Nanodrop machine and 
its concentration and purity were determined. 
 
Determining expression levels of genes of interest 
 The expression levels of genes were observed using the RT-PCR method.  
Primer design:  
Primers were designed using NCBI Primer BLAST. Several parameters were 
assigned when designing the primers: the size of the product was maintained to a suitable 
size such that the sequences were not from the same exon, the G-C content was 
maintained between 40 to 60 percent, the melting temperature was maintained below 
65°C as that was the upper limit of the Quantitech Studio qPCR machine, and the self-
complementarity was maintained to a minimum to prevent non-specific reactions. The 
selected primers were sent to Invitrogen for synthesis.  
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 Once the primers were received from Invitrogen, they were diluted to 100 uM 
using nuclease free water. The melting temperature of the primers was calculated by 
adding up the temperature values associated with each nucleotide: each G and C 
nucleotide added 4°C while every A and T nucleotide added 2°C. The average melting 
temperature of the primers was calculated, and the annealing temperature was designated 
to be 5°C less than the estimated melting temperature.  
 
Reverse Transcription (RT) of RNAs to cDNAs 
Total RNA extracted from hESCs was reverse transcribed to cDNA using the high 
capacity RNA-to-cDNA kit from Thermofisher Scientific. This kit is designed for 
optimal performance with the SYBR Green PCR Master Mix that is utilized for the qPCR 
protocol. 200 ng of RNA was used in reverse transcription. The procedure involves 
formulating a master mix comprised of 5 uL of 2x RT buffer mix, and 0.5 uL of RT 
enzyme per reaction well. This study involved 36 samples and therefore, at least 180 uL 
of RT buffer and 18 uL of RT enzyme were required; however, to account for any 
possible sources of error, 200 uL of RT buffer and 20 uL of RT enzyme were prepared, 
corresponding to 40 reactions. Each reaction well was destined to have a total volume of 
10 uL, with 5.5 uL of which was the master mixture. However, as the RNA was to be 
diluted to the point where it was approximately 2ng, the addition of 4.5uL of the RNA 
solution was not possible. As such, the proper volumes of RNA sample required were 
calculated. The reaction wells each received 5.5 uL master mix, the calculated amoun of 
RNAs, and nuclease free water for a total of 10 uL of reaction volume. It was imperative 
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to perform the reaction as quickly as possible once the RT enzyme was added as it 
immediately starts to react and that would cause errors in the production of cDNA. The 
reaction plate was placed in a Techne TC-4000 thermocycler and a preset reverse 
transcription protocol was run. The newly synthesized cDNA samples were placed in a -
20 degree freezer.  
 
 Quantitative Polymerase chain reaction (qPCR) Protocol: 
 For the PCR protocol, the primer solution was diluted from 100 uM to 2 uM. This 
was done by adding to a tube 10 uL of the primer stock solution and 490 uL nuclease free 
water. A master mixture was formulated comprised of Phusion High Fidelity Buffer, 10 
mM dNTPs, reverse transcribed cDNA, and Phusion Polymerase. 5uL of both the 
forward and reverse primers was added to a separate tube and 10uL of the master mix 
was added to each tube. The tubes were then centrifuged and put into the Tachne TC-
4000 thermocycler. The samples first underwent an initial denaturation stage at 98°C for 
30 seconds. This was followed by 30 cycles of the following parameters, 98°C for 10 
seconds, 58°C for 30 seconds, and 72°C for 30 seconds. After that, a final extension stage 
occurred at 72°C for 5 minutes and the samples are then held at 10°C.  
Gel Electrophoresis: 
 Gel electrophoresis was used to visually determine if the primers selected were 
successful in amplifying the genes of interest. The gel was prepared by adding 1 gram of 
agarose and 100mL of 0.5x TBE buffer to a flask. The flask was heated for 1 minute and 
then allowed to cool down until it can be touched comfortably. Once cool, 5uL of 
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Ethidium Bromide are added to the mixture, which was poured to a gel tray and allowed 
the agarose gel to solidify.  
 The solidified gel was placed into an agarose gel chamber, which was filled up to 
a designated point with the 0.5x TBE Buffer. On a parafilm, 2.5uL of 6x DNA loading 
dye was pipetted for each well and mixed with 5uL of the PCR product. This mixture was 
loaded into each individual well. 2.5 uL of the DNA loading dye is also mixed with 1 uL 
of 100 base pair DNA Ladder, which was used to determine the size of the amplicon to 
see if the correct gene product was produced. Electrodes were connected to the box and a 
device delivered 150V to the gel, allowing the DNA fragments to migrate. This was done 
for 1-1.5 hours.  
Once the samples and ladder had sufficiently migrated to the opposite pole, the 
gel was removed and placed in a Variable Intensity Transilluminator by Fisher Biotech. 
This machine has a camera installed into it as well as a UV light box. The Visionworks 
software was launched on the connected computer and a photograph was taken of the gel 
in designated conditions that were set to ensure the best possible photograph of the gel. 
The image was saved using Microsoft’s snipping tool, as the software itself was saving 
darker images than observed.   
 The expected size of the PCR product is determined using NCBI Primer BLAST. 
The forward and reverse primer sequences are inserted in their respective spots in the 
search engine and the genome is analyzed. The results screen shows different products in 
descending order of homology to the target sequence. The product size is given alongside 
other parameters of the product, such as its melting temperature, G-C content etc. The 
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size of the experimental amplicon determined by comparing its position relative to a 100 
base pair DNA ladder. If it was successfully expressed, the associated primer was 
selected to be used for qPCR analysis. If not, the primer pair was discarded, and a new 
primer pair was designed. 
 
Assessing the changes in ethanol induced gene expression by RT-qPCR:  
 hESCs were used as in vitro cellular models to minimize uncertainty caused by 
the environment. The gene expression of genes of the shelterin complex was analyzed. 
These genes included: TRF1, TRF2, POT1, TERT, RAP1 (TRF2IP), TINF2, and ACD.    
 
qPCR 
Expression levels were analyzed using the Quantitect SYBR Green PCR Kit 
(QIAGEN) in the QuantStudio 12K Flex Real-Time PCR System (ThermoFisher). The 
qPCR was performed on the gene of interest as well as a positive control, the beta-actin 
gene (ACTB).  
A master mixture was formulated which was comprised of 200 uL SYBR Green 
and 60 uL each of the forward and reverse primers of the gene of interest and ACTB. A 
96-well qPCR plate was labeled and divided for the two genes. 2 uL of cDNA was added 
into each designated well. This step was done first in order to confirm that the cDNA was 
added to each well. If the cDNA was added after the master mix, it would be impossible 
to confirm if it was incorporated into the well until after the qPCR process was complete 
and resources had been wasted. Afterwards, 8 uL of the master mix was added to each 
 
 
21 
 
well using a multichannel pipette and carefully mixed to prevent air bubbles in the wells. 
The qPCR plate was covered by an optical adhesive film to prevent the mixture from 
escaping the well and centrifuged. The plate was then transported in an ice box to the 
Analytical Instrument Core at Boston University.  
At the AIC, the plate was added to the Quantitech Flex Studio machine and the 
desired qPCR parameters were set up, either on the machine or the connected computer. 
The procedure began with an initial activation step at 95°C for 15 minutes. This was 
followed by 40 three-step cycles, with the three steps being denaturation, annealing, and 
extension. Denaturation occurred at 94°C for 15 seconds, the optimal annealing 
temperature was determined by the RT-PCR protocol (ranging from 55°C to 62°C), and 
extension took place at 72°C for 30 seconds. A melt curve analysis was also performed 
after the qPCR. Comparative ΔΔCt was used as a method of calculating changes in gene 
expression. Fold changes were calculated as 2-ΔΔCt. [ΔΔCt = ΔCt(ethanol-exposed) – 
ΔCt(ethanol-unexposed)]. This analysis was performed in Microsoft Office Excel 2019. 
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RESULTS 
Table 1: Concentrations of hESC RNAs determined using Nanodrop 
 
Sample ID ng/ul  260/280  260/230  
RNA 0mM 3 days A 210.54 2.06 2.03 
RNA 0mM 3 days B 227.43 2.08 1.17 
RNA 0mM 3 days C 154.4 2.08 1.29 
RNA 25mM 3 days A 326.05 2.04 1.26 
RNA 25mM 3 days B 295.83 2.07 1.12 
RNA 25mM 3 days C 303.49 2.07 1.88 
RNA 50mM 3 days A 194.22 2.1 0.95 
RNA 50mM 3 days B 158.4 2.08 0.62 
RNA 50mM 3 days C 217.5 1.98 1.51 
RNA 100mM 3 days A 171.97 2.09 1.93 
RNA 100mM 3 days B 276.2 2.08 0.85 
RNA 100mM 3 days C 229.17 2.09 1.66 
RNA 0mM 7 days A 179.53 2.05 0.51 
RNA 0mM 7 days B 124.8 1.86 1.42 
RNA 0mM 7 days C 139.03 1.97 1.69 
RNA 25mM 7 days A 50.36 1.86 1.49 
RNA 25mM 7 days B 150.29 2 0.41 
RNA 25mM 7 days C 88.1 2.03 0.2 
RNA 50mM 7 days A 116.89 2.08 0.27 
RNA 50mM 7 days B 120.24 2.01 0.72 
RNA 50mM 7 days C 77.69 1.89 0.79 
RNA 100mM 7 days A 107.31 2.01 1.87 
RNA 100mM 7 days B 92.61 1.99 0.79 
RNA 100mM 7 days C 119.67 2 1.21 
RNA 0mM 14 days A 231.3 2.05 1.08 
RNA 0mM 14 days B 194.82 2.07 1.05 
RNA 0mM 14 days C 211.23 2.08 0.51 
RNA 25mM 14 days A 245.04 2.03 1.91 
RNA 25mM 14 days B 295.7 2.05 2 
RNA 25mM 14 days C 190.33 2.04 0.88 
RNA 50mM 14 days A 273.42 2.06 2.02 
RNA 50mM 14 days B 114.32 1.93 0.92 
RNA 50mM 14 days C 113.56 1.95 0.92 
RNA 100mM 14 days A 306.08 2.06 2.02 
RNA 100mM 14 days B 259.67 2.05 1.93 
RNA 100mM 14 days C 199.57 2.06 1.55 
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Telomere length is affected by EtOH exposure in a time dependent manner
 
 
 
Figure 3: Amplification plot generated by Applied Biosystems™ QuantStudio™ 12K 
Flex Software of the RT-qPCR performed to measure fold changes of telomere length 
between control and experimental groups for H1 embryonic stem cells following EtOH 
treatment. a (up). Cycle numbers were plotted against ΔRn values with a threshold of 
449,904.160882 used to collect Ct values. b. (down) Melt curve plots were generated by 
Applied Biosystems™ QuantStudio™ 12K Flex Software of products from the qPCRs 
performed to measure telomere length between control and experimental samples. The 
derivative reporter fluorescence signal was plotted against the melting temperature (°C). 
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The Relative Human Telomere Length Quantification qPCR Assay Kit from 
ScienCell Research Laboratories was utilized to confirm the expression and amplification 
of the telomere sequence in relation to a reference sequence (SCR). The qPCR 
amplification plot depicted two clusters of curves, the one on the left corresponding to the 
telomere and the one on the right indicating the reference sequence. A melt curve 
analysis was also performed. This also showed two distinct, albeit proximal peaks, 
corresponding to two different products with the peak observed at a melting temperature 
of 82°C corresponding to the telomere sequence. These results indicate that the 
amplification of the telomere was performed correctly. 
Figure 4 (A) Fold changes in telomere length plotted against the exposure times for H1 
embryonic stem cells treated with 25 mM of EtOH for 3, 7, and 14 days (B) Fold changes 
in telomere length plotted against the exposure times for H1 embryonic stem cells treated 
with 50 mM of EtOH for 3, 7, and 14 days (C) Fold changes in telomere length plotted 
against the exposure times for H1 embryonic stem cells treated with 100 mM of EtOH for 
3, 7, and 14 days. All exposures were followed by 24 hours of withdrawal from EtOH.  
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Telomere length was determined by performing a ΔΔCt analysis, which was used 
to calculate the fold change induced by EtOH exposure. All three treated groups of 
hESCs exhibited an increase in fold change relative to the untreated cells 3 days 
following exposure: a 1.06, 1.10, and 1.24-fold change was observed for the group 
exposed to 25mM, 50mM and 100mM, respectively. After a 7-day exposure, a general 
decrease in fold change was observed for all but one group of samples. The group of 
samples treated with 50 mM EtOH for 7 days was determined to have a fold change of 
exactly 1.0 (Group B). Results like the groups exposed for 7 days, except the 50mM 
group, were observed for the groups exposed for 14 days, with a general decrease in fold 
change.  
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Table 2: Primers utilized for qPCR analysis and their optimal conditions determined by 
RT-PCR.  
 
Primer 
Name Nucleotide Sequence 
Annealing 
Temperature 
Amplicon 
size 
    
TRF2 F CAGACCAGTCCTTGTGGAATAA 61°C 354 bp 
TRF2 R GACACGAACACAGCACAATTAG 61°C 
    
POT1 F GCTCTGGCTTTGCATCTTTG 61°C 
269 bp 
POT1 R GGTGCCATCCCATACCTTTAG 61°C 
    
TINF2 F CTGAGCCCATGGAACAGAAT 58°C 
253 bp 
TINF2 R GGTGAGCCGAGATTCCTAAAG 58°C 
    
TRF1 F ACAGCGCAGAGGCTATTATTCA 60°C 
480 bp 
TRF1 R CTTTTGCCGCTGCCTTCATT 60°C 
    
ACD F GTCCCAGCTTCTGGATGAAA 62°C 
299 bp 
ACD R AGGCTATGAGGGTCAGAGATAG 62°C 
    
RAP1 F TAACGCCTTGTGGAAAGCGA 59°C 
578 bp 
RAP1 R CAGACGCTAAGAAGGCGGAA 59°C 
    
ACTB F AGCCATGTACGTTGCTATCC 58°C 
266 bp 
ACTB R CGTAGCACAGCTTCTCCTTAAT 58°C 
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Figure 5: Agarose Gel prepared with the primers that were utilized for qPCR. The order 
of the primers in the wells is as follows: TRF2, POT1, TINF2, TRF1, ACD, RAP1, and 
ACTB 
 
The efficacy of the primers at amplifying the desired mRNA products was 
ascertained by performing a PCR followed by gel electrophoresis (Figure 5).  All genes 
pertaining to the shelterin complex were successfully amplified. ACTB, with an amplicon 
size of 266 bp, was utilized as a reference gene for optimizing PCR conditions and 
normalizing the expression levels of shelterin complex genes. The expected amplicon 
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sizes for the POT1, TINF2 and ACD genes were 269, 253, and 299 bp, respectively. 
While the exact value cannot be determined via gel electrophoresis, the bands observed in 
their respective wells were observed between the second and third bands of the ladder, 
corresponding to 200 and 300bp. This implies that an amplicon was produced that 
exhibits a size that is expected of these three genes. TRF2 was expected to have a product 
with a size of 354 bp, and a band was observed between 300 and 400 bp, suggesting 
successful expression. The expected product size for TRF1 was 480 bp and its successful 
expression is indicated by a single band being observed between the 400 and 500 bp 
bands, leaning closer to the 500bp band. The product for RAP1 was expected to be 578 
bp in size and its expression is also supported by the band that migrated the least: it is 
observed to be found between the 500 and the 600bp bands. This master gel indicates the 
successful expression of all genes of interest.  
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(B) 
 
Figure 6: a) Amplification plots of RT-qPCR performed to measure change in TRF2 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot generated of qPCR 
products to measure levels of TRF2 and ACTB mRNA. Results produced by 
QuantStudio™ 12K Flex Software from Applied Biosystems. 
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The results of the qPCR performed to measure the expression levels of TRF2 
mRNA suggest successful expression of TRF2. The amplification plot depicted two 
distinct sets of curves that were far apart from one another. The samples amplified in 
earlier cycles, i.e. the leftward cluster of curves, corresponded to the housekeeping gene 
ACTB, and the set of samples that was amplified after 26 cycles corresponded to TRF2.  
The successful expression of TRF2 was further corroborated by the melt curve 
analysis, which also indicated two distinct sets of peaks, suggesting that non-specific 
amplification did not occur. It was expected that the peak that corresponded to ACTB be 
observed at 86.5°C. Therefore, the curve on the left was speculated to correspond to 
TRF2. Only one other distinct and sharp peak was observed, suggesting the amplification 
of another product, which could only be TRF2.  Therefore, TRF2 was successfully 
denatured 50% of the time at a melting temperature of approximately 81°C. 
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Figure 7: The degree of fold change of TRF2 mRNA was determined via ΔΔCt analysis 
performed on Microsoft Excel using the qPCR generated raw data. The fold change 
values were plotted again time for different concentrations of EtOH used to treat the 
cells. 
 
For hESCs treated with 25mM of EtOH, a linear trend of upregulation of TRF2 
was observed. Incubation of hESCs in ethanol for 3 days resulted in a 2.012-fold 
upregulation, followed by a 2.75-fold upregulation at 7 days of incubation and then a 
3.70-fold upregulation at 14 days.  
 Like the samples incubated at 25mM of EtOH, samples that were incubated in 
50mM of EtOH exhibited a trend of consistent upregulation as time passed, although this 
trend was not linear. Fold changes of 1.65, 1.38, and 1.66 were observed at 3, 7 and 14 
days, respectively.  
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 When cells were incubated at 100mM of EtOH, they were first upregulated, 
followed by a sharp relative decline in expression. The fold changes observed at 3, 7 and 
14 days were 1.53, 1.51 and 1.12, respectively.  
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Figure 8: A) Amplification plots of RT-qPCR performed to measure changes in POT1 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot of qPCR products to 
measure levels of POT1 and ACTB mRNA. Results produced by QuantStudio™ 12K 
Flex Software from Applied Biosystems. 
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The results of the qPCR performed to measure the expression levels of POT1 
mRNA suggest successful expression. While the curves observed in the amplification 
plot were near to each other, two distinct sets were distinguished. The first cluster of 
curves, observed after 18 cycles, was consistent with those observed for ACTB. A second 
cluster of curves was observed approximately after 24 cycles. This indicated the 
amplification of a second product, which is POT1. 
The successful expression of POT1 was further corroborated by the melt curve 
analysis, which also indicated two distinct set of peaks, suggesting that non-specific 
amplification of the PCR products did not occur. The curve on the right, at 86.5°C, was 
established to correlate to ACTB. As no other product was expected to form, it was 
assumed that the curve on the left corresponded to POT1. 
 
Figure 9: The degree of fold changes of POT1 mRNA was determined via ΔΔCt 
analysis performed on Microsoft Excel using the qPCR generated raw data. The fold 
change values were plotted again time for different concentrations of EtOH used to treat 
the cells. 
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POT1 was generally downregulated in cells treated with EtOH. For the cells 
incubated at 25mM EtOH, the fold changes measured in the first trial were 1.53, 1.04 and 
0.72 for 3, 7 and 14 days, respectively. For cells treated with 50mM EtOH, POT1 was 
downregulated by exposure. The fold changes observed in the first trial were 1.37, 0.86 
and 0.19 for 3, 7 and 14 days, respectively. hESCs incubated in 100mM EtOH exhibited 
a fold change of 1.33, .98 and 0.95 at 3, 7 and 14 days, respectively. 
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Figure 12: (A) Amplification plots of RT-qPCR performed to measure changes in TRF1 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot generated of qPCR 
products to measure levels of TRF1 and ACTB mRNA. Results produced by 
QuantStudio™ 12K Flex Software from Applied Biosystems 
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Expression levels of TRF1 mRNA were quantified successfully by qPCRs. While 
the curves observed in the amplification plot were near to each other, two distinct sets 
could be distinguished at the apex of the curves as there were two very distinct clusters of 
horizontal lines observed at the ΔRn range over 0.1. The first cluster of curves, observed 
after 18 cycles, was consistent with those observed for ACTB. A second cluster of curves 
was observed approximately after 20 cycles. This indicated the amplification of a second 
product, which is TRF1. 
The expression of TRF1 was further corroborated by the melt curve analysis, 
which also indicates two distinct set of peaks, suggesting that two specific PCR products 
(from ACTB and TRF1) were obtained. The curve on the right, at 86.5°C, was established 
to be correlated with ACTB. As no other product was expected to form, it was assumed 
that the curve on the left corresponded to TRF1.  
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Figure 11: The degree of fold changes of TRF1 mRNA was determined via ΔΔCt 
analysis performed on Microsoft Excel using the qPCR generated raw data. The fold 
change values were plotted again time for different concentrations of EtOH used to treat 
the cells. 
 
 
A uniform trend was observed for TRF1 across all three concentration dependent 
groups. There was an initial phase of downregulation followed by upregulation and 
downregulation once more. The 25mM group was recorded to have fold changes of .788, 
8.450, and 0.777, respectively. The 50mM group displayed expression behaviors that 
varied from the other shelterin subunits TRF1 interacted with. Fold changes of .651, 
18.101 and .259 were recorded at 3, 7 and 14 days of incubation, respectively. Lastly, the 
100mM group adhered to the established expression trends, with fold changes of 0.242, 
12.011, and .277 on 3, 7 and 14 days, respectively.  
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Figure 12: (A) Amplification plots of RT-qPCR performed to measure changes in TINF2 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot generated of qPCR 
products to measure levels of TINF2 and ACTB mRNA. Results produced by 
QuantStudio™ 12K Flex Software from Applied Biosystems 
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qPCRs were performed successfully to determine the expression levels of TINF2 
mRNA. Two very distinct sets of curves were observed. The first cluster of curves, 
observed after 16 cycles, was consistent with those observed for ACTB. A second cluster 
of curves was observed approximately after 22 cycles. This indicated the amplification of 
the target gene TINF2. 
The successful determination of TINF2 expression was further supported by the 
melt curve analysis, which also generated two distinct set of peaks, suggesting that no 
nonspecific amplification of the PCR products occurred. The curve on the right, at 
86.5°C, was established to correlate to ACTB. There was only one other peak observed in 
the melt curve apart from ACTB. The only one other product was formed, and this 
product was expected to be TINF2. 
 
Figure 13: The degree of fold changes of TINF2 mRNA was determined via 
ΔΔCt analysis performed on Microsoft Excel using the qPCR generated raw data. The 
fold change values were plotted again time for different concentrations of EtOH used to 
treat the cells. 
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The fold change trend that was observed for TINF2 as hESCs were treated with 
EtOH was consistent irrespective of the concentration.  
hESCs incubated in 25mM EtOH exhibited a fold change of 1.02, 1.24 and 1.51 at 
3, 7 and 14 days, respectively. Similarly, hESCs incubated in 50mM of EtOH, with fold 
changes of 0.76, 2.48 and 2.69 at 3, 7 and 14 days, respectively. hESCs treated with 
100mM of EtOH maintained the pattern observed for the prior two groups, with lower 
magnitudes of fold change. The fold change values measured were 0.52, 1.09 and 1.27 at 
3,7 and 14 days, respectively.  
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Figure 14: a) Amplification plots of RT-qPCR performed to measure changes in ACD 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot generated of qPCR 
products to measure levels of ACD and ACTB mRNA 
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All the results obtained pointed to the successful determination of ACD 
expression. The amplification plot for the qPCR exhibited two distinct sets of peaks, one 
of which corresponded to the housekeeping gene ACTB. The second set of peaks, 
therefore, was assumed to correspond to the gene of interest, ACD. There was no 
significant unspecific banding occurring, nor were primer dimers formed. The peaks for 
ACTB were the ones that began after about 15 cycles, while the peaks for ACD were 
observed after approximately 21 cycles of reaction.  
The melt curve plot results can be deceptive. While it may seem as if only a single 
product was generated, as only a single peak was observed, it is important to note that the 
product that was expected to be amplified for ACD had a molecular size almost identical 
to the housekeeping gene ACTB. Thus, the melting curve peaks for the housekeeping 
gene ACTB and ACD were overlapped.  
Further support of the expression of ACD was observed in the form of the gels 
that were prepared using RT-PCR. In the master gel, the ACD gene exhibited a single, 
sharp band (Figure 5). This suggests that the expected product was indeed successfully 
amplified, and no nonspecific bindings occurred.  
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Figure 15: The degree of fold changes of ACD mRNA was determined via ΔΔCt 
analysis performed on Microsoft Excel using the qPCR generated raw data. The fold 
change values were plotted again time for different concentrations of EtOH used to treat 
the cells. 
 
The fold change trend that was observed for ACD as hESCs were treated with 
EtOH was consistent irrespective of the concentration.  
hESCs incubated in 25mM EtOH exhibited a fold change of 1.34, 1.32 and 0.786 
at 3, 7 and 14 days, respectively. hESCs incubated in 50mM of EtOH exhibited only 
downregulation, with fold changes of .818, 0.769 and 0.712 at 3, 7 and 14 days, 
respectively. hESCs treated with 100mM of EtOH mimicked the trend exhibited by the 
25mM group with fold change values of 1.32, 1.13, and 0.80 at 3, 7, and 14 days, 
respectively.  
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Figure 16: a) Amplification plots of RT-qPCR performed to measure changes in RAP1 
mRNA levels in H1 hESCs exposed to EtOH. B) Melt curve plot generated of qPCR 
products to measure levels of RAP1 and ACTB mRNA 
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Figure 17: Image of gel electrophoresis performed to measure expression of RAP1, 
TINF2, and ACD. QPCR results produced by QuantStudio™ 12K Flex Software from 
Applied Biosystems and gel photo taken from VisionWorks software 
The qPCR performed to measure the expression levels of RAP1 mRNA provided 
conflicting results. The amplification plot depicted two distinct sets of curves, with the 
curves on the left corresponding to the housekeeping gene, ACTB, and the peaks on the 
right corresponded to RAP1.  The housekeeping gene ACTB was amplified beyond a 
threshold value of 0.04 after approximately 16 cycles. RAP1 was amplified above the 
threshold value after approximately 31 cycles.  
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While the amplification plot indicated two distinct set of peaks, the melt curve 
does not corroborate this. Instead, one sharp peak is visible and two faint peaks are also 
observed. It is expected that the housekeeping gene, β-actin, would be expressed at 
around 86.5°C and this is observed as the sharp peak, indicating proper amplification of 
the housekeeping gene. However, the fate of the amplification of RAP1 is uncertain.  A 
second prominent peak was not observed that would unequivocally establish the 
expression of RAP1. Instead, two faints but distinct peaks were observed, suggesting the 
presence of primer dimers or some form of nonspecific interactions among the 
nucleotides. However, it is assumed that the small peak observed underneath the ACTB 
peak is the one that corresponds with RAP1 as its expression was confirmed by the PCR 
and gel electrophoresis, in which single, very distinct bands were observed corresponding 
to the expected amplicon size for RAP1 (Figure 17).  
 
Figure 18: The degree of fold change of RAP1 mRNA was determined via ΔΔCt analysis 
performed on Microsoft Excel using the qPCR generated raw data. The fold change 
values were plotted again time for different concentrations of EtOH used to treat the 
cells. 
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For the RAP1 qPCR similar trends were observed for all 3 groups which were 
treated with different concentrations of EtOH. For the cells incubated at 25mM EtOH, the 
fold changes measured in the first trial were 1.02, 1.63 and 4.66 for 3, 7 and 14 days, 
respectively. For cells treated with 50mM EtOH, the fold changes observed in the first 
trial were 0.66, 3.61 and 3.30. The group of samples that were incubated for 3 days at 
50mM EtOH was the only one that exhibited downregulation. hESCs treated with 
100mM of EtOH, exhibited fold change values of 0.93, 2.73 and 3.91 at 3,7 and 14 days, 
respectively. 
 
Statistical Analysis 
Statistical analysis could not be performed for this set of data. The reason for this 
is because the different groups, separated by concentrations and the incubation time, were 
determined to be unpaired. Therefore, most statistical tests would not provide any 
meaningful results. 
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DISCUSSION 
Changes in telomere length were observed following chronic ethanol exposure. 
The findings of this study suggest that prolonged exposure to EtOH could have harmful 
effects on cellular maintenance and aging as it has been shown to decrease the length of 
the telomeres. Genes of the shelterin complex also had their expression levels altered 
because of chronic ethanol exposure. Subunits of the complex that have been documented 
to interact with one another exhibited similar alterations in gene expressions while those 
that acted independent of other proteins or complexes had varying trends.   
The expression of TRF2 was demonstrated to have a positive relationship with the 
duration of EtOH exposure, that is, higher expression levels were observed the longer the 
cells were incubated in EtOH. Given that it has been established both in this study and in 
literature that chronic alcohol exposure results in cellular aging, by way of telomere 
shortening, it is surprising that this ilk of a relationship would occur. TRF2 is responsible 
for the recruitment of several of the shelterin complex subunits and accessory factors and 
allows for them to have stable reactions (Figure 2). The result of these stabilized reaction 
is the successful recruitment of the key telomeric enzyme telomerase, which maintains 
the integrity of the telomere. Additionally, it also prevents the ATM kinase DNA damage 
response pathway which has been associated with shorter telomere length (Raynaud et 
al., 2008). It has been shown that in the absence of TRF2 or if there is some mutation in 
the TRF2 gene, DNA damage responses are triggered, which results in the shortening of 
telomeres (Denchi & de Lange, 2007).  These results suggest that chronic alcohol 
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exposure in fact, enhances the expression of TRF2 and thereby cause higher telomerase 
recruitment and activity, resulting in better maintenance of telomeres.  
While paradoxical, this upregulation in genes could imply that the shelterin 
complex attempts to adapt to stress related signals. In this case, the damage caused by the 
alcohol itself resulted in the overexpression of genes that are attempting to offset any 
potential loss or gain of function. It has been shown that one year of strenuous exercise 
diminished the age-related loss of telomere length due to altered gene expression in heart 
tissue of mice (Ludlow, Gratidão, Ludlow, Spangenburg, & Roth, 2017). Mice that were 
exposed to strenuous exercise exhibited an immediate response from TRF1, TRF2 and 
one of the two subunits of the mouse homologue of POT1, POT1a but not POT1b 
(Ludlow, Gratidão, Ludlow, Spangenburg, & Roth, 2017). To the contrary, in another 
study when athletes were exposed to acute stress, diminished expression levels of TRF2 
were observed (Chilton et al., 2014). The results in this study exhibit a similar trend: the 
group of cells exposed to alcohol for 3 days either had a minimal increase in fold change 
for the 25mM group while the 50mM and 100mM groups both had drastically lowered 
expression levels of TRF2. Telomerase activation has been correlated with the presence 
of DNA damage. When the telosome detects DNA damage, it upregulates the activity of 
telomerase and TRF2 in malignant cells (Klapper, Qian, Schulte, & Parwaresch, 2003).  
RAP1 exhibited a similar trend to TRF2, although the magnitudes of the fold 
changes differed. Acute exposure to EtOH resulted in downregulation of RAP1 but as 
time passed, it started to get expressed aggressively. An interesting observation made is 
that this trend mimics that of TRF2: TRF2 is also downregulated with acute EtOH 
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exposure and then its expression is upregulated remarkably as exposure was prolonged. 
This observation could be explained by the fact that the only shelterin subunit RAP1 
interacts with is TRF2, which is responsible for the co-localization of RAP1 to the 
telomeric DNA sequence. A mutation in each of the many domains of RAP1 has been 
shown to alter its affinity for TRF2 with variable effects. The most critical of these 
domains is the RCT domain, a knockout of which has been shown to entirely abolish 
interactions between RAP1 and TRF2 DNA (O’Connor, Safari, Liu, Qin, & Songyang, 
2004). This weakened affinity was also correlated to reduced localization of RAP1 to the 
telomeric DNA sequence. Given this RCT- dependent interaction between TRF2 and 
RAP1, it is unsurprising that their trends would be similar. In response to acute stress, 
TRF2 levels decline. As a result, there is less RCT-TRF2 binding occurring which 
informs the system that there is little need for RAP1 expression as it would serve no 
function as it cannot bind to TRF2. This thought is supported by the study performed by 
O’Connor et al. in which RCT deletion mutants resulted in weaker telomere elongation 
compared to fully functional RAP1 (O’Connor, Safari, Liu, Qin, & Songyang, 2004). 
Similarly, as time passes and DNA damage becomes more extensive, TRF2 expression 
increases (Figure 7). Consequently, RCT-TRF2 binding occurs more frequently and this 
signals the molecular machinery to produce more RAP1 in order to meet the needs of the 
damaged DNA and increased TRF2 levels. Overexpression of RAP1 has been shown to 
significantly increase the length of the telomeres. (Li & de Lange, 2003).  
The overall expression trend that was observed throughout the two weeks of 
EtOH incubation for TRF1 was similar to TRF2. Exposure to acute stress induced by 
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ethanol resulted in the downregulation of TRF1. This could simply be the result of the 
toxicity of the ethanol, which results in damaged cells with lower expression levels of the 
TRF1 gene. As time passed, TRF1 expression seems to have been rescued, possibly due 
to the cells adapting to the stress and attempting to restore normal functions by 
overexpressing genes that were damaged. This increase is expected as it has already been 
established in the literature that overexpression of TRF1 results in shortened telomeres 
while the presence of TRF1 mutants results in longer telomeres (van Steensel & de 
Lange, 1997). In a study performed by Takai et al., it was also shown that TRF2 and 
TINF2 had similar expression levels and the outcome of the telomeres was similar (Takai, 
Hooper, Blackwood, Gandhi, & de Lange, 2010). These findings were replicated as a part 
of this study: the shortening of telomeres and the overexpression of TRF1 and TRF2 were 
observed because of alcohol exposure. Lastly, after two weeks, the decline in TRF1 
expression could be explained by the cells being overwhelmed by the stress induced by 
ethanol and succumbing to it. Since the cells have started to decline, the machinery 
involved would also decline. This trend is also observed in TRF2, TINF2, ACD, and 
POT1.  
No consistent relationship between concentration and fold change was observed. 
In the 3-day group, a direct relationship between the concentration of alcohol and the 
gene expression levels of TRF1 is suggested but this is not supported by the other two 
groups. The 14-day group has an inverse relationship between the fold change and the 
alcohol concentration and the 7 day group follows neither of the aforementioned trends. 
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A direct relationship between the two parameters was expected as a higher concentration 
of alcohol would imply a higher degree of damage which would be correlated to shorter 
telomeres and in relation, a higher expression level of TRF1. The lowest concentration 
group consistently exhibited the highest degree of TRF2 expression while the 50mM and 
100mM groups had drastically lower expression levels. This highlights a multi-modal 
effect of alcohol in its efforts to reduce the length of a telomere and further highlights the 
significance of the entire telomere interactome, rather than just the shelterin complex 
itself. It could be that as the concentration of alcohol was increased, it had a direct 
inhibitory effect on the expression of TRF2. An explanation for why TRF1 is not affected 
in this manner but TRF2 is can be found in the composition of these two subunits. As 
mentioned earlier, TRF1 possesses an acidic N-terminus while TRF2 has a basic N-
terminus. The hydroxyl group of ethanol could be reacting with the N-terminus of TRF2 
resulting in a negative feedback loop. It is also possible that the alcohol is directly 
damaging the DNA rather than inhibiting the TRF2 genome.  
TINF2 is the shelterin subunit that is responsible for forming a bridge between 
TRF1 and TRF2 and is also involved in the recruitment of ACD. Additionally, loss of 
TINF2 has been shown to weaken the interaction between POT1 and telomeric ssDNA. 
The results of this study demonstrate that under the influence of alcohol, the expression 
levels of TINF2 increase, similar to TRF1 and TRF2 but converse to the effects on ACD 
and POT1. These findings are additional support to the results observed by Ye and De 
Lange, who observed that the reduction of TRF2 and TINF2 levels resulted in the 
elongation of telomeres (Ye and De Lange, 2004). As the telomere length is declining 
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after being exposed to alcohol, it is expected and observed that TINF2 expression levels 
will rise. What causes this rise in expression levels is up for debate. It could just be the 
cellular machinery attempting to compensate for the loss of function that results due to 
the damage caused by alcohol. This compensation could either be the direct induction of 
TINF2 or indirect induction of TINF2 due to higher demand caused by increased 
expression of TRF1 and TRF2. It is unclear as to why TINF2’s expression trends varied 
so drastically from those of POT1 and ACD, given that it interacts with those two as well 
and the trend of interacting molecules having similar expression tendencies.  
ACD showed an inverse relationship with incubation duration. ACD forms a 
complex with POT1 and this complex is responsible for the regulation of telomerase 
activity. ACD overexpression has been associated with lengthened telomeres and a drastic 
resistance to DNA damage (Yang et al., 2013).  Cells transfected with genes that allowed 
the overexpression of ACD showed significant elongation in their telomeres (Yang et al., 
2013) but this is controversial as some studies have also demonstrated no significant 
effects in cells overexpressing ACD (Ye et al., 2004).  However, it has been established 
that ACD is able to interact with telomerase and that its OB fold is essential for the proper 
recruitment of the telomerase enzyme (Xin et al., 2007). Therefore, it expected that 
altered ACD function would result in shortened telomeres through a telomerase 
dependent pathway. The results observed corroborate this hypothesized outcome as 
alcohol exposure has been shown to reduce telomere length. A possible explanation of 
this observation is that alcohol exposure disrupts the OB folds on the ACD subunit, 
thereby decreasing the affinity of telomerase for it, with the end product being a shorter 
 
 
55 
 
telomere. Alternatively, alcohol exposure could be inhibiting ACD’s ability to complex 
with POT1 because of which, the recruitment and activity of telomerase will be 
diminished, resulting in shorter telomeres.  
 Just like with the similarity in expression levels between TRF2 and RAP1 due to 
their interactions with one another, POT1 and ACD exhibit matching expression trends 
because they too interact with each other.  However, unlike with ACD, in which the 
50mM group exhibited an initial phase of downregulation, POT1 was upregulated 
consistently during acute exposure to EtOH, followed by downregulation as exposure 
became more chronic.  
Before delving into the relationship between POT1 and ACD, it would be prudent 
to analyze the gene expression results in the context of POT1 alone. POT1’s function is 
stated in its name: Protection of Telomeres. It accomplishes this by protecting the 
telomeric sequence from the DNA damage response pathway. In the absence of POT1, 
mouse embryonic fibroblasts succumbed to a DNA damage response on the telomeres 
that resulted in dysfunctional telomeres (Baumann & Price, 2010). Therefore, with lower 
levels of such a critical subunit, the telomeric DNA is much more susceptible to the DNA 
damage response pathway, resulting in its inevitable shortening being accelerated. Much 
support has been found for this notion as studies have shown that with lower expression 
of POT1, telomere length is reduced marginally (Wang, Mei, Fu, Wang, & Shao, 2014; 
Poojary et al., 2017). Furthermore, POT1 mRNA levels were found to be positively 
controlled with telomere length in tumor tissues. Additionally, POT1 was the only 
shelterin subunit, alongside TRF2, that was shown to be involved in the regulation of 
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telomere length in tumorigenic tissue (Poojary et al., 2017). The initial increase in fold 
change can be the result of a similar reason as that observed with TRF2, that is, the 
shelterin genes when exposed to acute stress increase their expression in order to 
compensate for the damage occurred.  
Looking at the relationship between ACD and POT1 makes it clear why the two 
genes would have a similar expression trend. POT1 is speculated to interact with the 
telomeric DNA only in the form of a heterodimer with ACD (Xin, Liu, & Songyang, 
2008). This heterodimer is responsible for the regulation of telomerase activity as it alters 
the degree of access the enzyme has to the telomeric DNA sequences. It also enhances 
the processivity of the telomerase component TERT (Wang et al., 2007).  Since alcohol 
exposure has been shown to decrease the length of the telomeres, it could be done so via 
this pathway: the expression of POT1 is diminished which results in lower recruitment 
levels of ACD to the single stranded telomeric DNA and since these two do not complex 
as much as healthy cells, they are less capable of recruiting telomerase.  
 Interestingly, POT1 does not follow the same concentration-dependent gene 
expression trend as many of the shelterin genes, which had an inverse relationship with 
the concentration of EtOH they were incubated in.  
TERT could not be analyzed as the multitude of primers designed for it failed to 
amplify it to a desirable degree. A study performed on the same cells checking the 
expression levels of TERT faced the exact same predicament and a suggestion was made 
to add more cDNA for the qPCR as the levels of TERT mRNA could have been low. 
Despite this modification, TERT amplification could not successfully be accomplished 
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via RT-PCR. Another troubleshooting suggestion that was made in the predecessor study 
was that a poor reverse transcription reaction could have taken place. However, this was 
accounted for as all other genes presented in this study were the products of the same 
reverse transcription protocol. The negligent expression could be because the primers 
could not bind to their desired target.   
Limitations 
The most critical limitations in this experiment was the finite amount of sample 
that was available for study on the shelterin complex. Due to high demand, some of the 
resources for this study had to be allocated for another project and that resulted in single 
qPCR analyses for several genes of the shelterin complex in hESCs. This can easily be 
rectified by culturing more hESCs, but unfortunately that would have taken more time 
and resources than were available.  
Future Direction 
 Due to time being a limited resource, this study’s original intent of comparing 
hESC models to post mortem human brain tissue models could not be realized. As such, a 
potential future study that must be performed in order to gain a better understanding of 
the effect of ethanol of telomere dynamics is to perform said study.  
This study focused solely on telomere dynamics in ethanol-treated embryonic 
stem cells and as such, another possible study could be to compare the effects of ethanol 
on the epigenetics of telomeres in different cell lines to gain a better understanding.  
 Further investigation should be performed on hESCs, with longer exposure 
periods in order to ascertain or deny whether the rescuing of the shelterin genes was a 
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product of chance, an unknown mechanism or a cyclical phenomenon that could not be 
study due to limited temporal parameters. 
 Another study that could be performed is to study the effects of alcohol on the 
individual interactions between the shelterin subunits that are known to associate with 
one another and recruit other factors.   
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